Adrian Gilbert
6Patents
4h-index
15Co-inventors
50Inventor score
Filing activity: Jan 12, 2000 → Aug 7, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6214791A | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 | Human Necessities | 63 | Expired |
| US7022663B2 | Oral, nasal and pulmonary dosage formulations of copolymer 1 | Human Necessities | 38 | Expired |
| US7989473B2 | Stable laquinimod preparations | Human Necessities | 14 | Active |
| US8383645B2 | Stable laquinimod preparations | Human Necessities | 9 | Active |
| US7294687B2 | Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus | Performing Operations; Transporting | 2 | Expired |
| US8022104B2 | Formulations of ladostigil tartrate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.